Clinical trial

Pharmacokinetics and Safety/Tolerability Profile of CKD-379

NCT05452525

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2022-07-26

PhasePHASE1

Study timeline

Study start (actual)2022-07-26Date precision: day

Registry last updated2022-10-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type II Diabetes Mellitusunresolved

Interventions

CKD-379 IDRUG

CKD-379 IIDRUG

D759+D745+D150DRUG

Sponsors & collaborators

Chong Kun Dang Pharmaceuticallead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05452525 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.